The role of regulatory reforms, market changes, and technology development to make demand response a viable resource in meeting energy challenges von Shen, Bo, Ghatikar, Girish, Lei, Zeng, Li, Jinkai, Wikler, Greg, Martin, Phil

Volltext

Assessment of U.S. Electric End-Use Energy Efficiency Potential von Gellings, Clark W., Wikler, Greg, Ghosh, Debyani

Volltext

The role of regulatory reforms, market changes, and technology development to make demand response a viable resource in meeting energy challenges : Energy innovations for a sustain... von BO SHEN, GHATIKAR, Girish, ZENG LEI, JINKAI LI, WIKLER, Greg, MARTIN, Phil

Volltext

The potential for energy efficiency in electric end use technologies von Wikler, G., Faruqui, A., Gellings, C.W., Seiden, K.

Volltext

DSM opportunities for India von Rubinstein, Ellen, Faruqui, Ahmad, Wikler, Greg, Shaffer, Susan

Volltext

DSM opportunities for India: A case study von Rubinstein, Ellen, Faruqui, Ahmad, Wikler, Greg, Shaffer, Susan

Volltext

Mitigating rate impacts of DSM programs von Chamberlin, John, Herman, Patricia, Wikler, Greg

Volltext

The Long View of Demand-Side Management Programs von Faruqui, Ahmad, Wikler, Greg, Bran, Ingrid

Volltext

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study von Corey, G. Ralph, Good, Samantha, Jiang, Hai, Moeck, Greg, Wikler, Matthew, Green, Sinikka, Manos, Paul, Keech, Richard, Singh, Rajesh, Heller, Barry, Bubnova, Natalia, O'Riordan, William

Volltext

Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subse... von Corey, G. Ralph, Arhin, Francis F, Wikler, Matthew A, Sahm, Daniel F, Kreiswirth, Barry N, Mediavilla, José R, Good, Samantha, Fiset, Claude, Jiang, Hai, Moeck, Greg, Kabler, Heidi, Green, Sinikka, O'Riordan, William

Volltext

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO... von Corey, G Ralph, Loutit, Jeffery, Moeck, Greg, Wikler, Matthew, Dudley, Michael N, O'Riordan, William

Volltext

1331The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) von Corey, Ralph, Wikler, Matthew, Moeck, Greg, Jiang, Hai, Good, Samantha

Volltext

Socioeconomic differences in health von CLEARY, Paul D, HUEFNER, Robert P, WAITZMAN, Norman J

Volltext